Advisor Group Holdings, Inc. Novavax Inc Transaction History

Advisor Group Holdings, Inc.

$40.6 Billion
Q2 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Novavax Inc stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 34,131 shares of NVAX stock, worth $464,522. This represents 0.0% of its overall portfolio holdings.

Number of Shares

34,131

Previous 75,891 55.03%

Holding current value

$464,522

Previous $362,000 19.34%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$3.89 - $20.97 $162,446 - $875,707	-41,760 Reduced 55.03%	34,131 $432,000
Q1 2024 May 10, 2024	SELL	$3.76 - $6.02 $17,461 - $27,956	-4,644 Reduced 5.77%	75,891 $362,000
Q4 2023 Feb 12, 2024	SELL	$4.8 - $7.67 $28,459 - $45,475	-5,929 Reduced 6.86%	80,535 $386,000
Q3 2023 Nov 13, 2023	BUY	$6.81 - $9.74 $73,772 - $105,513	10,833 Added 14.32%	86,464 $625,000
Q2 2023 Aug 10, 2023	BUY	$6.67 - $9.52 $78,852 - $112,545	11,822 Added 18.53%	75,631 $561,000
Q1 2023 May 12, 2023	BUY	$5.76 - $12.48 $44,755 - $96,969	7,770 Added 13.87%	63,809 $442,000
Q4 2022 Feb 10, 2023	BUY	$8.86 - $25.04 $68,638 - $193,984	7,747 Added 16.04%	56,039 $576,000
Q3 2022 Nov 14, 2022	SELL	$18.2 - $76.12 $85,103 - $355,937	-4,676 Reduced 8.83%	48,292 $878,000
Q2 2022 Aug 10, 2022	SELL	$36.28 - $75.29 $640,813 - $1.33 Million	-17,663 Reduced 25.01%	52,968 $2.73 Million
Q1 2022 May 04, 2022	BUY	$69.73 - $142.9 $1.49 Million - $3.05 Million	21,362 Added 43.36%	70,631 $5.08 Million
Q3 2021 Nov 05, 2021	BUY	$177.8 - $270.58 $637,590 - $970,299	3,586 Added 7.85%	49,269 $10.2 Million
Q2 2021 Aug 02, 2021	SELL	$121.0 - $257.67 $226,996 - $483,388	-1,876 Reduced 3.94%	45,683 $9.7 Million
Q1 2021 May 13, 2021	SELL	$112.98 - $319.93 $524,566 - $1.49 Million	-4,643 Reduced 8.89%	47,559 $8.63 Million
Q4 2020 Feb 10, 2021	BUY	$78.74 - $139.5 $1.53 Million - $2.71 Million	19,444 Added 59.36%	52,202 $5.82 Million
Q3 2020 Nov 12, 2020	BUY	$79.44 - $178.51 $6,990 - $15,708	88 Added 0.27%	32,758 $3.49 Million
Q2 2020 Aug 14, 2020	SELL	$13.86 - $83.61 $241,912 - $1.46 Million	-17,454 Reduced 34.82%	32,670 $2.72 Million
Q1 2020 May 18, 2020	BUY	$3.93 - $16.0 $196,987 - $801,984	50,124 New	50,124 $687,000

Others Institutions Holding NVAX

# of Institutions

284

Shares Held

83.2M

Call Options Held

5.43M

Put Options Held

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $1.06B
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Novavax Inc Transaction History